Athira Pharma Inc reports results for the quarter ended in June - Earnings Summary

LeonaBio

14/08/2023 13:00

* Athira Pharma Inc  ATHA.OQ  reported a quarterly adjusted
loss
of 78 cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 78
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Athira Pharma Inc's reported EPS for the quarter was a
loss
of 78 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Athira Pharma Inc shares had fallen by 4.7% this
quarter and
lost 11.4% so far this year.
    * The company reported a quarterly loss of $29.6 million.
    * Wall Street's median 12-month price target for Athira
Pharma Inc
is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.78          -0.78          Met
 Mar. 31 2023      -0.62          -0.73          Missed
 Dec. 31 2022      -0.67          -0.53          Beat
 Sep. 30 2022      -0.63          -0.53          Beat